Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Funding history
Its JAM (Joint Atomic Model) platform uses protein sequence, structure, and Nabla-generated experimental measurements for de novo biologics design, affinity/developability optimization, and multispecific therapeutic design, with a focus on difficult targets such as GPCRs, ion channels, and transporters.
Its JAM (Joint Atomic Model) platform uses protein sequence, structure, and Nabla-generated experimental measurements for de novo biologics design, affinity/developability optimization, and multispecific therapeutic design, with a focus on difficult targets such as GPCRs, ion channels, and transporters.
3 open jobs
Nabla Bio·1 hour ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Nabla Bio·1 hour ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Nabla Bio·1 hour ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
